why choose us

Clinical Trials Search

Showing 15,720 of 132,963 result(s)
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

Status: Completed

Condition: Pain

Interventions: SBS-1000 administered as a single continuous IV infusion over 60 minutes

Date: 2023-01-31

Responders to Rhythmic Auditory Cueing in Parkinson Disease

Status: Completed

Condition: Parkinson Disease

Interventions: Walking with metronome-based RAS cueing

Date: 2023-01-31

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Status: Completed

Condition: Chronic Kidney Diseases

Interventions: 10mg (milligram) tablet to be taken orally once daily for 6 months.
Manufacturer: Astrazeneca.
Study drug will be stored and dispensed by th

Date: 2023-01-31

Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty

Status: Completed

Condition: Aging

Interventions: Participants will be offered the opportunity to choose from a number of physical function assessments and subsequently provided personalized reports o

Date: 2023-01-31

Melatonin and Sleep Spindles in Autism

Status: Completed

Condition: Autism Spectrum Disorder

Interventions: 5mg gummy 30 min before bedtime for 2 consecutive nights

Date: 2023-01-30

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Status: Completed

Condition: Renal Cell Carcinoma

Interventions: 100 mg; 4mL on Day 1 of each 3- or 6- week cycle (one 3 wk cycle; up to eight 6 wk cycles)

Date: 2023-01-30

Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence

Status: Completed

Condition: Fecal Incontinence

Interventions:

Patients will be given home biofeedback device to take home and practice biofeedback exercises at least twice a day for six weeks of therapy.

Date: 2023-01-30

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

Status: Completed

Condition: Breast Cancer

Interventions: o In Phase A (~32 weeks), AT will consist of supervised walking delivered up to 7 days per week using an adaptive dosing schedule that starts at 90 mi

Date: 2023-01-30

Blueberries, Inflammation, Motivation, and Physical Activity

Status: Completed

Condition: Depressive Symptoms

Interventions: Participants will be asked to consume 48 grams of freeze-dried blueberry powder (~ equivalent to 2 cups of fresh blueberries) daily for 12 weeks.

Date: 2023-01-30

REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant

Status: Completed

Condition: Delirium in Old Age

Interventions: Administer Suvorexant versus placebo every evening for Post-Operative Day (POD) 0,1, &2

Date: 2023-01-30